Skip to main content

Animations

MJFF Publications

1091 - 1100 of 6420 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2025
  • 2025
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Telephone-based cognitive behavioral therapy for depression in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000009292
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-66319-9
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Mitofusin 2 displays fusion-independent roles in proteostasis surveillance
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56673-5
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Patient-centered brain transcriptomic and multimodal imaging determinants of clinical progression, physical activity, and treatment needs in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00878-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscs
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02517-x
    Citation Count: 1
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Ethnoracial differences for caregiving burden in Parkinson’s disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105927
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson’s Disease
    Journal Name: Neuropsychiatric Disease and Treatment
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/ndt.s485339
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci183592
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Brain age in genetic and idiopathic Parkinson's disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae382
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.